Delving into the Latest Updates on Shanghai Shiya Pharmaceutical Technology Co., Ltd. with Synapse

Overview

Tags

Eye Diseases

Chemical drugs

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

No Data

Top 5 Drug Type	Count

Chemical drugs	1

Primary objectives: (1) Evaluate the safety of SY101 injection Secondary objectives: (1) Evaluate the pharmacokinetics and biodistribution characteristics of SY101 injection (2) Evaluate the radiation dosimetry of SY101 injection Exploratory objectives: Explore the imaging characteristics of SY101 injection in patient subjects

Start Date-

Sponsor / Collaborator

Mitro Biotech Co., Ltd.

[+1]

100 Clinical Results associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Deals associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Shanghai Shiya Pharmaceutical Technology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Phase 1 Clinical

Login to view more data